PPT-SLE Update “What’s New In Lupus”

Donald L Kimpel MD March 28 2015 Sentara Medical Center LFADMV The Many features and flavors of Systemic Lupus 11 ACR criteria ACR SLICC Plaquenil Eye Testing Diabetes and Lupus. Dr. Shauna O’Sullivan, DO, FACP. Assistant Professor of Medicine, USUHS. March 28, 2015. www.myquincy.net. Disclaimer. Nothing to disclose. The views and opinions expressed herein do not necessarily state or reflect those of the Naval Medical Center Portsmouth, DoD, or the United States . Christina McConnell, PGY-3. Which of the following is NOT one of the diagnostic criteria for lupus?. Biopsy proven lupus nephritis with a positive ANA. Hemolytic anemia. Psychosis. Single joint swelling. . Dr. : Mohamed . Abdelhafez. . . . . Nephrology specialist . . MNGH. Agenda. DEFINITION AND EPIDEMIOLOGY. ETIOLOGY AND PATHOGENESIS. RENAL AND EXTRARENAL MANIFESTATIONS. IMMUNOLOGIC TESTS IN LUPUS NEPHRITIS. T. issue Disease. (What is the relationship between UCTD and SLE?). R. John Looney, MD. Stephen and Elise Rosenfeld Distinguished Professor of Allergy and Clinical Immunology. Looking for Lupus. Copyright © 1972-2004 American College of Rheumatology Slide Collection. All rights reserved.. WAY AHEAD, RE—POSTURE FORCE AND TRANSITION TO . DoS. 22-24 . Mar: . SLE. with . XXXX. . OPORD XX-XX PHASE ONE: STRENGTHEN AND SET CONDITIONS FOR REDEPLOYMENT. 15-17 . Mar: . SLE. with . XXXX. and . Ella Obrosky, SRNA, University of Pittsburgh Nurse Anesthesia Program. Introduction to Autoimmune Disease. ADs are a heterogeneous group of diseases characterized loss of self-tolerance. Significant . , Antiphospholipid. . Syndrome and Systemic Lupus Erythematosus). Sandeep . Singh, . MD, Shoaib Junejo, MD, Adriana Abrudescu, MD, FACR. ,. . Isaac Sachmechi, MD, FACE, FACP.. Department of Medicine/Rheumatology/Endocrinology Icahn School Of Medicine at Mount . MD.DM. Rheumatologist & Clinical Immunologist. Sir . Gangaram. Hospital New Delhi. . Demographic details. NAME : . B. AGE/SEX : . 24years/F. CR NO : . 201601101994. ADM NO : . 2016004242. ADDRESS : . Dimitrios. T. . Boumpas. (. leader. ), George Bertsias (. facilitator. ), on behalf of the Study Group members. The EULAR study Group on SLE was established in 2011 and has the following . objectives. . Discussion and Conclusion. Reference. Systemic lupus erythematosus (SLE) is a chronic inflammatory disease that primarily effects women with an 8:1 prevalence. Renal disease and gastrointestinal (GI) symptoms are very common presentations of lupus, seen in 50% of patients. Dr. Konstantinos Tselios, MD, PhD. Assistant Professor. McMaster University. Objectives. To discuss the cumulative data for safety and efficacy from the development program of anifrolumab (MUSE, TULIP-1 and TULIP-2 trials) for non-renal, non-neuropsychiatric SLE. Neurology AsiaMarch 2021 immunosuppressive therapy on an individualized level followed by stable maintenance therapy of appropriate strength and duration. The outcome of SLE-ATM is variable and the re . By. Dr. Muhammad Abdullah Shwani. Assistant professor/Consultant urologist. Kurdistan Higher Council of Medical Specialties (KHCMS). drmalshwani@mail.com. Diseases. By: . Dr. . Eman. . Almukhadeb. Consultant dermatologist, Assistant professor . Objectives . At the conclusion of . this . lectures the student . should be . able to. :. Differentiate . between the various types of Lupus.